We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+15.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$7.66B
AUM Growth
+$3.01B
Cap. Flow
+$2.59B
Cap. Flow %
33.75%
Top 10 Hldgs %
13.68%
Holding
1,708
New
716
Increased
217
Reduced
186
Closed
462

Top Buys

Rank Stock Value
1
DRI icon
Darden Restaurants
DRI
+$68.5M
2
META icon
Meta Platforms (Facebook)
META
+$33.2M
3
BIIB icon
Biogen
BIIB
+$28.4M
4
DVN icon
Devon Energy
DVN
+$26.5M
5
FCX icon
Freeport-McMoran
FCX
+$21.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$23.4M
2
NEM icon
Newmont
NEM
+$18.8M
3
CYH icon
Community Health Systems
CYH
+$15.2M
4
CNC icon
Centene
CNC
+$13.5M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$11.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.72%
2 Healthcare 3.45%
3 Technology 1.57%
4 Materials 1.15%
5 Communication Services 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEAM icon
1301
PUT
Beam Therapeutics
BEAM
$2.63B
– –
-25,000
Closed -$2M
BEPC icon
1302
Brookfield Renewable
BEPC
$6.08B
– –
-42,500
Closed -$1.99M
BEPC icon
1303
PUT
Brookfield Renewable
BEPC
$6.08B
– –
-85,000
Closed -$3.98M
BHF icon
1304
Brighthouse Financial
BHF
$3.56B
– –
-9,800
Closed -$433K
BIDU icon
1305
Baidu
BIDU
$37.7B
– –
-1,000
Closed -$218K
BILL icon
1306
PUT
BILL Holdings
BILL
$4.49B
– –
-150,000
Closed -$21.8M
BMRN icon
1307
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-140,400
Closed -$10.6M
BMRN icon
1308
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-25,399
Closed -$1.92M
BMRN icon
1309
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-121,400
Closed -$9.17M
BNS icon
1310
Scotiabank
BNS
$107B
– –
-7,500
Closed -$485K
BOX icon
1311
Box
BOX
$4.37B
– –
-92,049
Closed -$2.15M
BP icon
1312
CALL
BP
BP
$116B
– –
-200,000
Closed -$4.87M
BRFS
1313
DELISTED
BRF SA
BRFS
– –
-50,000
Closed -$223K
BTAI icon
1314
CALL
BioXcel Therapeutics
BTAI
$24.9M
– –
-288
Closed -$197K
BTAI icon
1315
BioXcel Therapeutics
BTAI
$24.9M
– –
-2,500
Closed -$1.73M
BTAI icon
1316
PUT
BioXcel Therapeutics
BTAI
$24.9M
– –
-2,544
Closed -$1.76M
BTG icon
1317
B2Gold
BTG
$5B
– –
-31,500
Closed -$154K
BXP icon
1318
Boston Properties
BXP
$11.2B
– –
-10,000
Closed -$1.01M
BXP icon
1319
PUT
Boston Properties
BXP
$11.2B
– –
-50,000
Closed -$5.06M
CALM icon
1320
Cal-Maine
CALM
$4.12B
– –
-60,000
Closed -$2.31M
CALX icon
1321
PUT
Calix
CALX
$2.26B
– –
-18,000
Closed -$624K
CAR icon
1322
Avis
CAR
$4.86B
– –
-24,800
Closed -$2.06M
CCS icon
1323
Century Communities
CCS
$1.91B
– –
-11,000
Closed -$663K
CGEN icon
1324
Compugen
CGEN
$222M
– –
-30,000
Closed -$258K
CHTR icon
1325
CALL
Charter Communications
CHTR
$17.3B
– –
-50,000
Closed -$30.9M
51 52
53
54 55

Similar funds

ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Caption Management's Q2 2021 Portfolio in Review

As of Q2 2021, Caption Management held 1,708 positions worth $7.66B, up 65% from $4.65B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management deployed $2.59B of net new capital in Q2 2021, opening 716 new positions and adding to 217 existing holdings. Its largest new stake was Darden Restaurants: 486,800 shares worth $71.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.7% of assets, down from 4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Amgen, an estimated $23.4M trimmed.

  • Caption Management's largest Q2 2021 buy was Darden Restaurants: 486,800 shares worth $71.1M.
  • Caption Management added most to Meta Platforms (Facebook) in Q2 2021, an estimated $33.2M increase.
  • Caption Management's biggest Q2 2021 reduction was Amgen, cutting an estimated $23.4M.
  • Caption Management fully exited Community Health Systems in Q2 2021, selling an estimated $15.2M.
  • Caption Management's ten largest holdings make up 14% of its $7.66B portfolio in Q2 2021.
  • Caption Management opened 716 new positions and closed 462 in Q2 2021.
  • Caption Management's portfolio value rose 65% quarter-over-quarter to $7.66B.

Based on Caption Management's 13F filing for Q2 2021, filed 16 Aug 2021.